Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
针对 HDAC3 和 HDAC1 的组蛋白去乙酰化酶 (HDAC) 抑制剂可改善亨廷顿氏病模型系统中聚谷氨酰胺引起的表型
期刊:Neurobiology of Disease
影响因子:5.1
doi:10.1016/j.nbd.2012.01.016
Haiqun Jia, Judit Pallos, Vincent Jacques, Alice Lau, Bin Tang, Andrew Cooper, Adeela Syed, Judith Purcell, Yi Chen, Shefali Sharma, Gavin R Sangrey, Shayna B Darnell, Heather Plasterer, Ghazaleh Sadri-Vakili, Joel M Gottesfeld, Leslie M Thompson, James R Rusche, J Lawrence Marsh, Elizabeth A Thomas
